Optimized optogenetic anti-CRISPR for endogenous gene regulation in Drosophila
Nucleic Acids Research · 2026
DOI: 10.1093/nar/gkag244 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2026. Verfasst von Clarissien Ramongolalaina und 3 weiteren Autor:innen. Beteiligte Einrichtung: Aging and Regeneration Center, School of Basic Medical Sciences, Tsinghua Medicine, Medical Science Building, Room D204, Tsinghua University, Beijing…. Hauptthemen laut MEDLINE: Optogenetics, Gene Expression Regulation, CRISPR-Cas Systems, Drosophila melanogaster. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tsinghua-Peking Center of Life Sciences, J. C. Pastor-Pareja, National Natural Science Foundation of China.
Abstract (Originalsprache)
Optogenetic tools—light-responsive proteins that enable to regulate specific cellular activities, study biological processes, and develop new therapies—are attractive approaches for achieving endogenous gene regulation under minimally invasive conditions. Our first step in constructing an optogenetic system to regulate endogenous Drosophila gene expression was to identify inhibitory anti-CRISPR (Acr) proteins that block CRISPRa-mediated activation. Next, we inserted optogenetic protein LOV2 into these Acrs, tested for their ability to optogenetically modulate endogenous gene upregulation through the CRISPRa-based flySAM system in Drosophila, and found that the photoswitchability of these prototypes was weak. We therefore engineered an optimized Acr–LOV2 fusion module by refining length of intrinsically disordered and ordered regions (IDR and IOR) of Acrs. This optimization yielded a variant with significantly greater sensitivity to blue-light-induced endogenous gene upregulation than the prototypes, leading to new in vivo discoveries. In addition, this work provides insights for in vivo functional characterization of the IDR and the IOR of these small-sized proteins. Together, these findings establish a robust optogenetic toolbox for precise, light-controlled endogenous gene regulation in Drosophila.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Aging and Regeneration Center, School of Basic Medical Sciences, Tsinghua Medicine, Medical Science Building, Room D204, Tsinghua University, Beijing 100084, China.
- The State Key Laboratory for Complex, Severe, and Rare Diseases, Beijing 100084, China.
- School of Life Science, Tsinghua University, Beijing 100084, China.
- IDG/McGovern Institute for Brain Research at Tsinghua, Beijing 100084, China.
- Tsinghua-Peking Joint Center for Life Sciences, Beijing 100084, China.
- Institute of Neurosciences, Consejo Superior de Investigaciones Científicas-Universidad Miguel Hernández, San Juan de Alicante 03550, Spain.
ORCID-Profile: Clarissien Ramongolalaina
Förderung
- Tsinghua-Peking Center of Life Sciences
- J. C. Pastor-Pareja
- National Natural Science Foundation of China
- Ministerio de Ciencia, Innovación y Universidades
- "Severo Ochoa" Program for Centers of Excellence
- State Key Laboratory of Complex, Severe, and Rare Diseases
- Changping Laboratory
- SXMU-Tsinghua Collaborative Innovation Center for Frontier Medicine
Zitieren
APA
Ramongolalaina, C., Pastor-Pareja, J. C., Zhang, E., & Jia, Y. (2026). Optimized optogenetic anti-CRISPR for endogenous gene regulation in Drosophila. Nucleic Acids Research. https://doi.org/10.1093/nar/gkag244
Vancouver
Ramongolalaina C, Pastor-Pareja JC, Zhang E, Jia Y. Optimized optogenetic anti-CRISPR for endogenous gene regulation in Drosophila. Nucleic Acids Research. 2026. doi:10.1093/nar/gkag244
BibTeX
@article{Ramongolalaina2026,
author = {Ramongolalaina, Clarissien and Pastor-Pareja, José C and Zhang, Emily and Jia, Yichang},
title = {Optimized optogenetic anti-CRISPR for endogenous gene regulation in Drosophila},
journal = {Nucleic Acids Research},
year = {2026},
doi = {10.1093/nar/gkag244}
}
EUVIMED